Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis.Published in:Current Hypertension Reports, 2019, v. 21, n. 2, p. N.PAG, doi. 10.1007/s11906-019-0920-4By:Sternlicht, Hillel;Bakris, George L.Publication type:Article
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?Published in:Blood Purification, 2016, v. 41, n. 1-3, p. 139, doi. 10.1159/000441264By:Sternlicht, Hillel;Bakris, George L.Publication type:Article
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists.Published in:Current Diabetes Reports, 2022, v. 22, n. 5, p. 213, doi. 10.1007/s11892-022-01461-4By:Cohen, Scott;Sternlicht, Hillel;Bakris, George L.Publication type:Article
Hypercalcemia of malignancy and new treatment options.Published in:2015By:Sternlicht, Hillel;Glezerman, Ilya G.Publication type:journal article